Skip to main content
DP

Diligent Pharma

Diligent Pharma is a platform that employs a data-driven methodology to enhance the selection and qualification process for clinical trial service providers. This approach reduces the time and complexity involved in trial setups, leading to more efficient and reliable clinical research outcomes.

Philadelphia, United StatesFounded 2018251K+ followers
Updated 20 months ago

Funding

$8.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

FV
Funding rounds are not available yet.

Founders

Product

Problem

Pharmaceutical and biotech companies face significant challenges in the selection and qualification of clinical trial service providers, leading to delays and increased costs. Redundant qualification activities across different organizations contribute to wasted resources and inefficiencies in the clinical trial process.

Solution

Diligent Pharma offers a vendor qualification ecosystem that connects pharmaceutical and biotech sponsors with a global network of qualified GCP and GCLP providers. The platform provides access to qualification questionnaires and audit reports, accelerating study launch timelines. By centralizing vendor qualification data, Diligent Pharma eliminates redundant activities, allowing sponsors to benefit from a single qualification assessment. This approach streamlines partner discovery, improves risk awareness, and ensures compliance with global regulatory requirements.

Target Audience

The primary customers are pharmaceutical and biotech sponsors seeking to streamline vendor qualification, reduce costs, and improve compliance in clinical trials.

Features

  • Access to a network of Diligent Qualified GCP and GCLP Providers.
  • Library of high-quality qualification questionnaires and audit reports.
  • Centralized source of qualification data mapped to global regulatory requirements.
  • Streamlined vendor qualification timeline, reducing the process to less than a week.
  • Risk-based decision making across clinical trial service categories.
  • Pre-scheduled vendor qualification audits tailored to specific requirements.
This profile is AI-generated and may contain inaccuracies.